Ryan Spencer
Net Worth

Last updated:

What is Ryan Spencer net worth?

The estimated net worth of Mr. Ryan Spencer is at least $7,798,983 as of 10 Feb 2024. He owns shares worth $1,508,716 as insider, has earned $1,130,327 from insider trading and has received compensation worth at least $5,159,940 in Dynavax Technologies Corporation.

What is the salary of Ryan Spencer?

Mr. Ryan Spencer salary is $859,990 per year as Chief Executive Officer & Director in Dynavax Technologies Corporation.

How old is Ryan Spencer?

Mr. Ryan Spencer is 47 years old, born in 1978.

What stocks does Ryan Spencer currently own?

As insider, Mr. Ryan Spencer owns shares in one company:

Company Title Shares Price per share Total value
Dynavax Technologies Corporation (DVAX) Chief Executive Officer & Director 144,513 $10.44 $1,508,716

What does Dynavax Technologies Corporation do?

Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.

Ryan Spencer insider trading

Dynavax Technologies Corporation

Mr. Ryan Spencer has made 4 insider trades between 2019-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 280,000 units of DVAX stock on 16 Feb 2023. As of 10 Feb 2024 he still owns at least 144,513 units of DVAX stock.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted Stock Unit 20,833 N/A N/A
Option
Common Stock 20,833 N/A N/A
Option
Common Stock 29,750 N/A N/A
Option
Restricted Stock Unit 29,750 N/A N/A
Option
Restricted Stock Unit 20,834 N/A N/A
Option
Common Stock 9,888 N/A N/A
Option
Common Stock 29,750 N/A N/A
Option
Restricted Stock Unit 29,750 N/A N/A
Option
Common Stock 20,834 N/A N/A
Option
Stock Option (Right to Buy) 280,000 $11.12 $3,113,600
Sale
Common Stock 14,921 $16.92 $252,404
Option
Restricted Stock Unit 29,663 N/A N/A
Option
Common Stock 29,663 N/A N/A
Sale
Common Stock 52,835 $10.56 $557,938
Sale
Common Stock 17,611 $10.57 $186,148
Option
Restricted Stock Unit 20,833 N/A N/A
Sale
Common Stock 12,662 $10.57 $133,837
Option
Restricted Stock Unit 29,750 N/A N/A
Option
Common Stock 29,750 N/A N/A
Option
Common Stock 20,833 N/A N/A
Option
Common Stock 89,250 N/A N/A
Option
Restricted Stock Unit 89,250 N/A N/A
Option
Common Stock 20,833 N/A N/A
Option
Restricted Stock Unit 20,833 N/A N/A
Option
Common Stock 27,209 N/A N/A
Option
Restricted Stock Unit 27,209 N/A N/A
Option
Restricted Stock Unit 1,562 N/A N/A
Option
Common Stock 1,562 N/A N/A
Option
Common Stock 4,875 N/A N/A
Option
Restricted Stock Unit 4,875 N/A N/A